Long‐term efficacy and safety of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: 104‐week VERTIS MET trial

AIM: To evaluate the long‐term efficacy and safety of ertugliflozin in adults with type 2 diabetes mellitus inadequately controlled on metformin. MATERIALS AND METHODS: A 104‐week Phase III, randomized double‐blind study with a 26‐week placebo‐controlled period (Phase A) and a 78‐week period (Phase...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallo, Silvina, Charbonnel, Bernard, Goldman, Allison, Shi, Harry, Huyck, Susan, Darekar, Amanda, Lauring, Brett, Terra, Steven G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593724/
https://www.ncbi.nlm.nih.gov/pubmed/30614616
http://dx.doi.org/10.1111/dom.13631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593724/
https://www.ncbi.nlm.nih.gov/pubmed/30614616
http://dx.doi.org/10.1111/dom.13631

Ejemplares similares